In patients with MPO-AAV and glomerulonephritis, it has been recently described that persistence or subsequent reappearance of MPO-ANCA is associated with a higher risk of relapse, while MPO-ANCA negativity stratifies a low risk for relapse even without remission maintenance therapy [59]. Here, MPO is linked to glomerulonephritis.